Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside
Immune checkpoint inhibitors have transformed the landscape of oncological therapy, but at the price of a new array of immune related adverse events. Among these is β-cell failure, leading to checkpoint inhibitor-related autoimmune diabetes (CIADM) which entails substantial long-term morbidity. As o...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Frontiers Media S.A.
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/1e56972a31f348d590db8b50daff2a0b |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!